Introduction
The mottled mice are an allelic series of mouse mutants that are due to mutations in the murine orthologue of the X-linked Menkes genes (Atp7a) [1, 2] . The mutant males exhibit a wide range of phenotypes ranging from prenatal lethality to mild symptoms such as a grey coat [3] . The carrier females are readily identified because they have a mottled coat due to the random X-inactivation while the unaffected mice have an agouti coat [4] .
As with the human disorder Menkes disease, the various defects in the mice are attributable to copper deficiency affecting a range of copper-dependent enzymes [5] . The uptake of copper across the small intestine and transport of copper across the blood brain barrier [11] . The fact that copper accumulates in the kidney of the brindled mouse indicates that Atp7a has a role in resorption of copper from the urine. Copper is absorbed into the proximal tubules, but because of the lack of Atp7a, the copper is trapped in cells and accumulates in the organ [12] . The Menkes protein is not expressed in hepatocytes [13] , where the important copper homeostatic mechanism of biliary copper excretion is carried out by the closely related protein, ATP7B which is defective in the copper toxicity condition, Wilson disease [14] .
To investigate the possibility of gene correction of Menkes disease we report here the use of transgenic mice that express the human Menkes protein (ATP7A) to demonstrate that the human Menkes gene (ATP7A) allows survival of the brindled mutant, the mouse model of Menkes disease. Despite expression patterns that do not entirely match the endogenous gene, the corrected mice are fertile and survive for more than two years, but the phenotype of the mutant males corrected with the transgenic line T25#5 resembled that of the heterozygote females.
Material and methods

Animals
All animal studies were approved by Deakin University Animal Welfare Committee (A1/1999 and A20/A2001). Animals were housed under constant conditions with a 12 h light and 12 h dark cycle, and given deionised water and standard lab chow (Barastoc, Ridley AgriProducts, Australia) ad libitum. The transgenic mice were maintained in the C57BL/6 background, and the brindled allele of the X-linked mottled mutants, Atp7a
Mo -b r in our laboratory is maintained on a C3H/CBA background.
Brain, kidney, heart and lung were immersion-fixed in 4% PFA in PBS for 5 -24 h at 4°C, embedded in paraffin and sectioned at 4 µm on a Microm HM330 microtome (Walldorf, Germany Australia) and mounted with DXT (Chem-Supply, Gillman, SA, Australia).
Real time quantitative polymerase chain reaction
Total RNA was isolated using the Qiagen Rneasy Mini Kit according to the manufacture's instructions (Qiagen, Clifton Hill, Vic, Australia). cDNA was generated from 5 µg RNA using StrataScript® reverse transcriptase (Stratagene, East Kew, Vic, Australia) following the manufacturer's instructions. The specific primers for ATP7A
were (5'-GCTACCTTGTCAGACACGAATGAG, and 5'-TCTTGAACTGGTGTCATCCCTTT) and for Atp7a were (5'-AAACCTTGCGAGAAGCAATTG, and 5'-GGGCAAAAGAGGTGTTTCCA 
Determination of tissue copper concentration
Tissues were analyzed for trace metals by flame atomic absorption spectrometry, using a Varian GTA 100 spectrophotometer (Mulgrave, Vic, Australia).
Results
Correction of the Menkes defect in the mottled mouse mutant
We used two lines of transgenic mice (T25#5 and T22#2) expressing the human Menkes gene to correct the brindled mutants. The generation and characteristic of the lines is described elsewhere [15] . In these lines ATP7A is regulated by the chicken β-actin promoter (CAG) and the transgene was found to be widely expressed with some differences in expression pattern between the lines. To introduce the CAG-ATP7A
transgene into the mutant brindled males, T25#5 or T22#2 transgenic male mice were mated with non-transgenic females heterozygous for the Atp7a
Mo-br X-linked mottled allele. Pups were genotyped by PCR of tail DNA for their transgenic status and for the brindled mutation using allele-specific oligonucleotides, as described in Material and
Methods. Amplification of the mutant allele generated a 83 bp PCR product compared to a 87 bp fragment from the wild type allele as previously described [8] . Fig. 1A shows the PCR results from the four possible Atp7a genotypes generated from such mating (transgene status is not shown). Out of the total number of 148 pups genotyped at d9 postnatal, 19 were found to be uncorrected brindled mutants and 18 were found to be corrected mutants, the predicted number being 18.5. The uncorrected mutant males were hypopigmented ( Fig.2A) and died between 14 and 20 days. The transgenes permitted survival of the mutant but surprisingly the T25#5 corrected mutants ( Fig. 2C and D) had a mottled coat similar to the heterozygous females (Fig. 2B) . Apart from the mottling of the coat of the T25#5 corrected mutant males, corrected mutant males appear in good health and have survived for more than 2 years. Their growth rate was similar to the normal male littermates (Fig. 1B) Subsequently we investigated the correction by a different transgenic line, T22#2.
Interestingly, T22#2 corrected males had an agouti coat colour similar to their wild type littermates ( Fig. 2E and F) but otherwise were similar in health, growth rate and longevity compared with the T25#5 corrected males. The corrected mutant males of both lines had straight whiskers (note Fig. 2C , D, E and F) contrasting with the curly whiskers of the uncorrected mutant ( Fig. 2A ), which are caused by copper deficiency.
Transgene expression in the corrected mutant males
The expression of the ATP7A protein and ATP7A mRNA levels in a range of tissues from T25#5 corrected mutant males were determined by Western blot analysis ( . ATP7A mRNA expression levels relative to Atp7a levels were markedly increased in heart (244 fold), small intestine (38 fold), brain (11 fold), lung (7 fold), kidney (3 fold) and spleen (2 fold). Lower expression levels were measured in liver (1.7 fold) consistent with the Western blot results.
The cellular distribution of ATP7A in various organs was determined by immunohistochemistry using the R17-BX antibody. Endogenous Atp7a was undetectable in non-transgenic mice under the conditions used (data not shown). The transgene was expressed in a mosaic pattern in most tissues examined (Fig. 4) . In the lung ATP7A was detected in smooth muscle of pulmonary vessels, but not in the parenchyma (Fig. 4A ). In the heart the transgene was expressed in cardiac muscle (Fig. 4B) . In the liver, we found expression of the transgene in clusters of hepatocytes (Fig. 4C) , however, the majority of hepatocytes did not appear to express ATP7A. Interestingly the protein appeared to be at the plasma membrane rather than in an intracellular location as was seen in most other cell types. In the small intestine the transgene was expressed in the perinuclear region on the apical side of the enterocytes (Fig. 4D ) consistent with the TGN localization in these cells reported by Monty et al [17] . In kidney the transgene was expressed in the macular densa of the distal tubules (Fig. 4E) , in tubules in the outer cortex (Fig. 4F) , as well as in the thin loops of Henle in the outer medulla (data not shown). In the brain, we found transgene expression in the Purkinje cell layer of the cerebellum (Fig. 4G) , in the CA1 and CA2 region of the hippocampus (Fig. 4H) , the mitral layer of olfactory bulb and in some instances in the vascular endothelium (data not shown). Some expression was detected in the choroid plexus but we could not detect expression in astrocytes (data not shown).
Effect of ATP7A expression on Cu concentration in corrected mice
Copper concentrations in the mice were determined at 12 days (Table 1 ) and 60 days postnatal (Table 2 ). Copper concentrations in the heart of the uncorrected mutant male at 12 days of age were much lower than normal (8.8 ± 2.1 µg/g v 24.1 ± 9.7 µg/g) but the copper concentrations were restored to normal levels in the heart of the corrected mutants. In the liver the normal males and female had high copper concentrations typically found in mice prior to weaning [18] . The uncorrected male mutant and the Copper concentrations in the tissues of the 60 day-old animals is shown in Table 2 .
The uncorrected mutant males had all died by this age. Copper concentrations in the corrected mutants heart and liver were normal. In the kidney of the corrected males the copper concentrations were almost 6 fold higher than the normal males, and were similar
to the values seen in the heterozygous females expressing the transgene; the non-transgenic heterozygous females, however, had renal copper concentrations approximately 9 fold higher than normal females. The small intestine copper levels were slightly elevated in the corrected mutant males, and again resembled the values seen in the heterozygous females. By this age the brain copper concentrations of all genotypes was similar.
Discussion
The expression of the human Menkes protein permitted survival of the brindled mutant males, however, the copper concentrations were not restored to those found in the normal male but were similar to copper concentrations in the heterozygous females. As we found here and previously reported [19, 20] , the females heterozygous for the Our data suggests that, like the heterozygous female, the males corrected with the T25#5 transgene are a genetic mosaic of transgene-expressing or non-expressing cells (eg Fig. 4) . The consequences for coat colour and tissue copper accumulation are similar to that seen in the heterozygous females, however, the exact phenotype will depend on the pattern of transgene inactivation, which is likely to vary between lines of mice and possibly even between individuals of the same line. The observation that the corrected males of the T22#2 line have a normal coat suggests that the transgene in this line is uniformly expressed in the skin, but other data has shown mosaic expression in other tissues [15] . Mosaic expression of transgenes is not uncommon and presumably reflects random silencing events as was shown for the keratin 5/lacZ constructs which express in a mosaic fashion in the epithelium of transgenic mice [22] and may be a consequence of the chromosomal integration site or transgene copy number [23] . We have not investigated the site of integration of the transgene or the copy number in transgenic lines T25#5 and T22#2, however, PCR screening for presence of the transgene suggests that the copy number of the T22#2 line is higher than that of the T25#5 line (not shown). Variable transgene expression has been reported for a number of genes regulated by the CAG promoter [24] [25] [26] . Although this property could potentially be an issue if one is considering gene correction for Menkes disease, our results demonstrate that even partial correction is sufficient to achieve normal growth and development.
ATP7A expression and ATP7A mRNA levels were found to vary widely between the tissues of the corrected mutant mice. Expression was highest in the heart muscle cells where the levels were over two hundred times relative to the endogenous mRNA. In cells where the endogenous protein was detectable, such as the kidney, relative levels were about 3 fold higher than the endogenous gene. The high relative expression in the heart is due to a combination of the high activity of the CAG promoter in muscle cells [26] and the very low endogenous levels in this tissue.
The over-expression of ATP7A did not result in apparently abnormal intracellular distribution of the protein as it was found in regions consistent with the transGolgi network, the established location of the Menkes protein in a normal copper environment [27] . Elevated levels of ATP7A in cells has shown to cause depletion of copper, due to enhanced efflux of copper [28, 29] , and this effect is apparent in the trend for reduced copper concentrations in the hearts of the transgenic animals ( Table 2 ) [15] . It has not been established whether this copper depletion has any physiological consequences for the heart.
ATP7A was expressed in patches of hepatocytes in the liver of the corrected mice, and unlike other cell types appeared located on the plasma membrane, rather than in a region consistent with the TGN. It is probably that this region is the basolateral surface of the hepatocyte, as ATP7A has been shown to traffic to the basolateral surface in polarized cells [30] and proteins that are located on the apical surface of hepatocytes give a characteristic discrete circular staining pattern [31, 32] . Normally hepatocytes do not express ATP7A, instead they express the closely related Wilson protein, ATP7B [31] .
When the copper levels in the hepatocyte are low, ATP7B is found in the TGN, but the protein traffics to large vesicles in the vicinity of the biliary canalicular membrane when the copper levels are elevated leading to biliary excretion of copper [31] . Our result suggests a physiological reason for the lack of ATP7A expression in the liver in normal animals. If ATP7A were normally expressed in hepatocytes it would presumably pump copper into the sinusoidal space, and hence back into the circulation, rather than delivering excess copper into the bile and act in opposition to the biliary excretion role of ATP7B. It will be of interest to explore further the physiological consequences of this presumed reversal of copper flow in further experiments.
Although the pattern of expression of the transgene in tissues did not precisely match that of the reported expression patterns of the endogenous gene [12] , ATP7A was expressed in the tissues critically important for the survival of the mutant mice. For example, ATP7A was well expressed in the intestinal enterocytes where copper accumulates in mutants when the Menkes protein is defective [19] , and this expression presumably allows the absorption of dietary copper. Recently Monty et al. have shown that ATP7A in the intestinal enterocytes of the ATP7A transgenic mice responded to increasing copper in the lumen of the small intestine by trafficking from a perinuclear region to vesicles in the basolateral region, presumably facilitating copper delivery to the circulation [17] . The fact that the brain copper is restored to normal is of critical importance for the survival of the mice. The Menkes protein is thought to be necessary for the transport of copper across the blood brain barrier, and in mutant mice copper has been found to accumulate in the vascular endothelium and astroglial cells of the mouse brain [33] . Surprisingly we could not detect consistent expression of the transgene in the vascular endothelial cells or astrocytes, nevertheless we suggest that a low but undetectable amount of ATP7A must have been present, otherwise copper would not have been able to reach the brain. We note that our antibodies are not sensitive enough to detect endogenous levels of Atp7a, so expression of the transgene at levels equivalent to the normal protein may not have been visible in the sections. We detected substantial amounts of ATP7A in the Purkinje cell layer of the cerebellum, in the CA1 and CA2 region of the hippocampus and in the mitral layer of olfactory bulb, which are also reported to express the Atp7a in normal mice [12, 34] . This expression of the transgene may have assisted in the restoration of normal brain function, however, the complete role of the Menkes protein and indeed copper in the brain is far from clear.
In Menkes patients copper accumulates in the proximal tubules of the kidney, the place of copper resorption [11] . We found ATP7A expression in the macular densa of the distal tubules, in tubules in the outer cortex, as well as in the thin loops of Henle in the outer medulla, which was sufficient to reduce the copper levels of the corrected mutant males compared to the heterozygote females. Comparison of transgene expression with the endogenous Atp7a is complicated by the differences in published reports of the expression pattern of Atp7a in the kidney. For example, strong endogenous Atp7a expression was found by in situ hybridization studies in the proximal tubules, however low levels of expression were found in the glomeruli [35] . Moore and Cox found strong endogenous expression in the glomeruli using in situ hybridization and slight expression in the interior of various tubules [36] . We have previously detected Atp7a in both the proximal and distal convoluted tubules with little staining in the glomeruli [8] .
Normally the livers of fetal mice accumulate copper far above the adult levels, and the high concentrations are maintained throughout the first 10-15 days of life [18] . The uncorrected mutant has an extremely low hepatic copper concentration of 10.7 ± 2.4 µg/g at 12 days compared with the normal male littermate (164.5 ± 70.6 µg/g), consistent with the severe copper deficiency of the mutants. This low liver copper is primarily due to the defective transport of copper across the mutant placenta [7] . The transgene only partially corrects this deficiency, with the hepatic copper being only 15.8 ± 4.5 µg/g. This value
suggests that the expression of the transgene must be moderately restricted in the placenta but we have not assessed placental expression. Interestingly the 12 day-old heterozygous females have low hepatic copper as well (14.9 ± 3.6 µg/g) which may be due to the preferential inactivation of the normal paternal allele in the placenta leaving most of the fetal placenta with the mutant X active [37] . The transgene in the heterozygous females In conclusion the rescue of the brindled mutants demonstrates that even partial correction of the Menkes genetic defect in humans would be sufficient for relatively normal development and these mice also will provide further information about the role of the Menkes ATPase in copper physiology. 
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